Argentine woman sues AstraZeneca and state over alleged vaccine‑induced Guillain‑Barré
Flavia Ochoa, a resident of Coronel Moldes in Córdoba Province, filed a civil lawsuit against AstraZeneca and the Argentine national government, alleging that the third dose of the AstraZeneca COVID‑19 vaccine she received on 4 January 2022 caused a severe neurological condition. Hours after vaccination she experienced intense muscle cramps and, the following day, a progressive loss of mobility. Medical examinations at a private sanatorium in Río Cuarto diagnosed her with Guillain‑Barré syndrome with quadriparesis. A medical assessment recorded a permanent occupational disability of 75.6 %. Ochoa’s suit seeks compensation for the disability, moral damages, loss of life project and other harms, and requests access to the reparations fund established under Law 27.573, which regulates vaccine procurement and provides compensation for vaccine‑related injuries. The lawsuit also challenges the earlier dismissal by the National Vaccine Safety Commission, which had found no causal link between the vaccine and her condition. The case remains pending, with the court to determine the causality.
Entities: AstraZeneca · Flavia Ochoa · Guillain‑Barré syndrome · Law 27.573 · National Vaccine Safety Commission
Claims
What the coverage asserts, and how well corroborated each claim is across sources.
- [● 3 SOURCES] Hours after vaccination she experienced severe muscle cramps and the next day loss of mobility. (multiple articles)
- [● 3 SOURCES] Medical assessment recorded a permanent occupational disability of 75.6 % for Ochoa. (multiple articles)
- [● 3 SOURCES] The case remains pending, with the court to determine causality between the vaccine and the condition. (multiple articles)
- [● 3 SOURCES] Ochoa filed a civil lawsuit against AstraZeneca and the Argentine state seeking compensation for disability, moral damages, loss of life project and other harms. (multiple articles)
- [● 3 SOURCES] The claim invokes Law 27.573, which created a reparations fund for vaccine injury victims. (multiple articles)
- [● 3 SOURCES] Flavia Ochoa received the third dose of the AstraZeneca COVID‑19 vaccine on 4 January 2022 in Coronel Moldes, Córdoba. (multiple articles)
- [● 3 SOURCES] The lawsuit challenges the earlier decision of the National Vaccine Safety Commission that rejected her claim of vaccine‑related injury. (multiple articles)
- [● 3 SOURCES] She was diagnosed with Guillain‑Barré syndrome with quadriparesis at a private sanatorium in Río Cuarto. (multiple articles)